{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:27:16Z","timestamp":1781620036839,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chinese National Research Grant of the Thirteenth Five-Year Plan for the Key Projects in Infectious Diseases","award":["2017ZX10201201"],"award-info":[{"award-number":["2017ZX10201201"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No.81673243"],"award-info":[{"award-number":["Grant No.81673243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZSM201911001"],"award-info":[{"award-number":["SZSM201911001"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Postpartum alanine transaminase (ALT) flares occur frequently in chronic hepatitis B virus (HBV)-infected mothers with antepartum antiviral therapy (AVT). We aimed to characterize the T cell immunity in HBV-infected mothers experiencing postpartum ALT flares.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty HBV-infected pregnant women who received AVT at 26\u201328\u00a0weeks of gestation were enrolled and followed up until 15\u201318\u00a0weeks postpartum. Among the 20 HBV-infected pregnant women, 6 experienced postpartum ALT flare (AF mothers), while 14 did not (NAF mothers). T lymphocyte phenotypes and functions were analyzed using flow cytometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to NAF mothers, the quantitative HBsAg levels in AF mothers decreased significantly at 6\u20138 or 15\u201318\u00a0weeks postpartum. Significant differences in HBeAg levels between these groups were only found at delivery. Regulatory T cell (Treg) numbers in AF mothers were lower than those of NAF mothers before AVT; however, there were no significant differences in Treg numbers at other follow-up points. Expression of other T cell phenotypes were similar between the two groups. T cells in AF mothers produced more pro-inflammatory cytokines (IFN-\u03b3, IL-21, TNF-\u03b1, IL-2) or less anti-inflammatory cytokine (IL-10) than those in NAF mothers before, during, or after antiviral treatment. The ratio of IFN-\u03b3 to IL-10 producing by CD4<jats:sup>+<\/jats:sup> T cells or CD8<jats:sup>+<\/jats:sup> T cells was higher in AF mothers than that in NAF mothers during pregnancy or after delivery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The characteristics of T cell immunity was distinct between mothers with postpartum ALT flare and those without ALT flare from pregnancy to postpartum, which indicated that T cell immunity might get involved in postpartum ALT flare.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06634-2","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T13:02:59Z","timestamp":1630933379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Characterization of T cell immunity in chronic hepatitis B virus-infected mothers with postpartum alanine transaminase flare"],"prefix":"10.1186","volume":"21","author":[{"given":"Meiting","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueru","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohua","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"key":"6634_CR1","unstructured":"World Health Organization. Fact sheet on hepatitis B. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed 27 July 2020."},{"issue":"7","key":"6634_CR2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/infdis\/jiy706","volume":"220","author":"W Su","year":"2019","unstructured":"Su W, Chen S, Yang C, Chuang P, Chang H, Chang M. The impact of universal infant hepatitis B immunization on reducing the hepatitis B carrier rate in pregnant women. J Infect Dis. 2019;220(7):1118\u201326.","journal-title":"J Infect Dis"},{"issue":"5","key":"6634_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00705-019-04190-4","volume":"164","author":"T Peng","year":"2019","unstructured":"Peng T, Cai Q, Yang M, Chen S, Chen F, Wang M, Peng L, Wong G, Shen C, Cheng W, et al. Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates. Arch Virol. 2019;164(5):1335\u201341.","journal-title":"Arch Virol"},{"issue":"2","key":"6634_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41575-020-00361-w","volume":"18","author":"NA Terrault","year":"2021","unstructured":"Terrault NA, Levy MT, Cheung KW, Jourdain G. Viral hepatitis and pregnancy. Nat Rev Gastroenterol Hepatol. 2021;18(2):117\u201330.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"6634_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jhep.2013.11.008","volume":"60","author":"W Yi","year":"2013","unstructured":"Yi W, Pan CQ, Hao J, Hu Y, Liu M, Li L, Liang D. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. J Hepatol. 2013;60(3):523\u20139.","journal-title":"J Hepatol"},{"issue":"2","key":"6634_CR6","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","volume":"19","author":"H Zou","year":"2012","unstructured":"Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19(2):e18\u201325.","journal-title":"J Viral Hepat"},{"issue":"24","key":"6634_CR7","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"374","author":"CQ Pan","year":"2016","unstructured":"Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324\u201334.","journal-title":"N Engl J Med"},{"issue":"1","key":"6634_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/hep.28302","volume":"63","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, McMahon BJ, Lok AS, Wong JB, Ahmed AT, Mouchli MA, Wang Z, Prokop LJ, Murad MH, Mohammed K. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis. Hepatology. 2016;63(1):319\u201333.","journal-title":"Hepatology"},{"issue":"1","key":"6634_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S1473-3099(20)30586-7","volume":"21","author":"AL Funk","year":"2021","unstructured":"Funk AL, Lu Y, Yoshida K, Zhao T, Boucheron P, van Holten J, Chou R, Bulterys M, Shimakawa Y. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):70\u201384.","journal-title":"Lancet Infect Dis"},{"key":"6634_CR10","first-page":"1374276","volume":"2020","author":"Z Li","year":"2020","unstructured":"Li Z, Duan X, Hu Y, Zhou M, Liu M, Kang K, Cai H, Yi W, Fu D, Gao X. Efficacy and safety of lamivudine or telbivudine in preventing mother-to-child transmission of hepatitis B virus: a real-world study. Biomed Res Int. 2020;2020:1374276.","journal-title":"Biomed Res Int"},{"issue":"8","key":"6634_CR11","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.14309\/ajg.0000000000000221","volume":"114","author":"NH Bzowej","year":"2019","unstructured":"Bzowej NH, Tran TT, Li R, Belle SH, Smith CI, Khalili M, Chung R, Tsai N, Terrault N. Total alanine aminotransferase (ALT) flares in pregnant North American women with chronic hepatitis B infection: results from a prospective observational study. Am J Gastroenterol. 2019;114(8):1283\u201391.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"6634_CR12","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/hep.27034","volume":"60","author":"H Zhang","year":"2014","unstructured":"Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology. 2014;60(2):468\u201376.","journal-title":"Hepatology"},{"issue":"10","key":"6634_CR13","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1708131","volume":"378","author":"G Jourdain","year":"2018","unstructured":"Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, Salvadori N, Cressey TR, Sirirungsi W, Achalapong J, et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N Engl J Med. 2018;378(10):911\u201323.","journal-title":"N Engl J Med"},{"issue":"2","key":"6634_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/eji.201948382","volume":"50","author":"YH Zhang","year":"2020","unstructured":"Zhang YH, Sun HX. Immune checkpoint molecules in pregnancy: focus on regulatory T cells. Eur J Immunol. 2020;50(2):160\u20139.","journal-title":"Eur J Immunol"},{"key":"6634_CR15","first-page":"253","volume":"5","author":"P Chatterjee","year":"2014","unstructured":"Chatterjee P, Chiasson VL, Bounds KR, Mitchell BM. Regulation of the anti-inflammatory cytokines interleukin-4 and interleukin-10 during pregnancy. Front Immunol. 2014;5:253.","journal-title":"Front Immunol"},{"issue":"1","key":"6634_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.4049\/jimmunol.0803654","volume":"183","author":"J Mjosberg","year":"2009","unstructured":"Mjosberg J, Svensson J, Johansson E, Hellstrom L, Casas R, Jenmalm MC, Boij R, Matthiesen L, Jonsson JI, Berg G, et al. Systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17 beta-estradiol. J Immunol. 2009;183(1):759\u201369.","journal-title":"J Immunol"},{"issue":"8","key":"6634_CR17","doi-asserted-by":"publisher","first-page":"5737","DOI":"10.4049\/jimmunol.180.8.5737","volume":"180","author":"T Tilburgs","year":"2008","unstructured":"Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA, Claas FH. Evidence for a selective migration of fetus-specific CD4+CD25 bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol. 2008;180(8):5737\u201345.","journal-title":"J Immunol"},{"issue":"2","key":"6634_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/hep4.1460","volume":"4","author":"SS Joshi","year":"2019","unstructured":"Joshi SS, Coffin CS. Hepatitis B and pregnancy: virologic and immunologic characteristics. Hepatol Commun. 2019;4(2):157\u201371.","journal-title":"Hepatol Commun"},{"issue":"s5","key":"6634_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-3083.1976.tb03851.x","volume":"5","author":"A B\u00f8yum","year":"1976","unstructured":"B\u00f8yum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol. 1976;5(s5):9\u201315.","journal-title":"Scand J Immunol"},{"key":"6634_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2016.12.002","volume":"313","author":"M Barathan","year":"2017","unstructured":"Barathan M, Mohamed R, Vadivelu J, Chang LY, Vignesh R, Krishnan J, Sigamani P, Saeidi A, Ram MR, Velu V, et al. CD8+ T cells of chronic HCV-infected patients express multiple negative immune checkpoints following stimulation with HCV peptides. Cell Immunol. 2017;313:1\u20139.","journal-title":"Cell Immunol"},{"issue":"2","key":"6634_CR21","doi-asserted-by":"publisher","first-page":"e12914","DOI":"10.1111\/sji.12914","volume":"92","author":"M Huang","year":"2020","unstructured":"Huang M, Gao Y, Liao D, Li J, Tang B, Ma Y, Yin X, Li Y, Liu Z. Effects of intrauterine exposure to maternal-derived HBeAg on T cell immunity in cord blood. Scand J Immunol. 2020;92(2):e12914.","journal-title":"Scand J Immunol"},{"issue":"2","key":"6634_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398.","journal-title":"J Hepatol"},{"key":"6634_CR23","unstructured":"Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. The guidelines of prevention and treatment for chronic hepatitis B (2019 version). Zhonghua Gan Zang Bing Za Zhi. 2019;27(12):938\u201361."},{"issue":"10","key":"6634_CR24","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.cgh.2018.10.007","volume":"17","author":"J Hou","year":"2019","unstructured":"Hou J, Cui F, Ding Y, Dou X, Duan Z, Han G, Jia J, Mao Q, Li J, Li Z, et al. Management algorithm for interrupting mother-to-child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2019;17(10):1929\u201336.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"6634_CR25","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1136\/gutjnl-2014-308211","volume":"64","author":"M Giles","year":"2015","unstructured":"Giles M, Visvanathan K, Lewin S, Bowden S, Locarnini S, Spelman T, Sasadeusz J. Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B. Gut. 2015;64(11):1810\u20135.","journal-title":"Gut"},{"issue":"10","key":"6634_CR26","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/ajg.2016.296","volume":"111","author":"CY Chang","year":"2016","unstructured":"Chang CY, Aziz N, Poongkunran M, Javaid A, Trinh HN, Lau D, Nguyen MH. Serum alanine aminotransferase and hepatitis B DNA flares in pregnant and postpartum women with chronic hepatitis B. Am J Gastroenterol. 2016;111(10):1410\u20135.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"6634_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41395-018-0010-2","volume":"113","author":"W Yi","year":"2018","unstructured":"Yi W, Pan CQ, Li M, Wan G, Lv Y, Liu M, Hu Y, Zhang Z, Xie Y. The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B. Am J Gastroenterol. 2018;113(5):686\u201393.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"6634_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/liv.13594","volume":"38","author":"T Kushner","year":"2018","unstructured":"Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, Krok K, Centkowski S, Dalldorf K, D\u2019Souza J, et al. Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: a regional hospital-based cohort study. Liver Int. 2018;38(5):813\u201320.","journal-title":"Liver Int"},{"issue":"4","key":"6634_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/hepr.13472","volume":"50","author":"C Liu","year":"2020","unstructured":"Liu C, Xu L, Xia C, Long Y, Liu C, Lu S, Song Y. Increased proportion of functional subpopulations in circulating regulatory T cells in patients with chronic hepatitis B. Hepatol Res. 2020;50(4):439\u201352.","journal-title":"Hepatol Res"},{"issue":"4","key":"6634_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/hep.20649","volume":"41","author":"JN Stoop","year":"2005","unstructured":"Stoop JN, van der Molen RG, Baan CC, van der Laan LJW, Kuipers EJ, Kusters JG, Janssen HLA. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology. 2005;41(4):771\u20138.","journal-title":"Hepatology"},{"issue":"3","key":"6634_CR31","doi-asserted-by":"publisher","first-page":"e1694","DOI":"10.1038\/cddis.2015.42","volume":"6","author":"B Ye","year":"2015","unstructured":"Ye B, Liu X, Li X, Kong H, Tian L, Chen Y. T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis. 2015;6(3):e1694.","journal-title":"Cell Death Dis"},{"issue":"1","key":"6634_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12879-019-3853-2","volume":"19","author":"Y Gu","year":"2019","unstructured":"Gu Y, Lian Y, Gu L, Chen L, Li X, Zhou L, Huang Y, Wang J, Huang Y. Correlations between cytokines produced by T cells and clinical-virological charact","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06634-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06634-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06634-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T13:03:40Z","timestamp":1630933420000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06634-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6634"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06634-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"assertion":[{"value":"9 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with Good Clinical Practice, following local regulations and ethical principles described in the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of Nanfang Hospital, Southern Medical University (IRB No. NFEC-2019-197), and written informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"922"}}